101 related articles for article (PubMed ID: 11403534)
1. Current indications for acid suppressants in dyspepsia.
Bytzer P; Talley NJ
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):385-400. PubMed ID: 11403534
[TBL] [Abstract][Full Text] [Related]
2. Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease.
Katz PO; Tutuian R
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):371-84. PubMed ID: 11403533
[TBL] [Abstract][Full Text] [Related]
3. Effects of proton-pump inhibitors on functional dyspepsia: a meta-analysis of randomized placebo-controlled trials.
Wang WH; Huang JQ; Zheng GF; Xia HH; Wong WM; Liu XG; Karlberg J; Wong BC
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):178-85; quiz 140. PubMed ID: 17174612
[TBL] [Abstract][Full Text] [Related]
4. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the management of dyspepsia.
Talley NJ; Vakil N;
Am J Gastroenterol; 2005 Oct; 100(10):2324-37. PubMed ID: 16181387
[TBL] [Abstract][Full Text] [Related]
6. Controlled trial of interventions to increase testing and treatment for Helicobacter pylori and reduce medication use in patients with chronic acid-related symptoms.
Majumdar SR; Ross-Degnan D; Farraye FA; Lee M; Kemp JA; Lecates RF; Henning JM; Tunis SR; Schrammel P; Soumerai SB
Aliment Pharmacol Ther; 2005 Apr; 21(8):1029-39. PubMed ID: 15813839
[TBL] [Abstract][Full Text] [Related]
7. A double blind, randomized, placebo-controlled trial of proton pump inhibitor therapy in patients with uninvestigated dyspepsia.
Rabeneck L; Souchek J; Wristers K; Menke T; Ambriz E; Huang I; Wray N
Am J Gastroenterol; 2002 Dec; 97(12):3045-51. PubMed ID: 12492188
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
9. Update on the role of drug therapy in non-ulcer dyspepsia.
Talley NJ
Rev Gastroenterol Disord; 2003; 3(1):25-30. PubMed ID: 12684590
[TBL] [Abstract][Full Text] [Related]
10. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
Vakil N
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
[TBL] [Abstract][Full Text] [Related]
11. Current indications for acid suppressants in Helicobacter pylori -negative ulcer disease.
Howden CW; Leontiadis GI
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):401-12. PubMed ID: 11403535
[TBL] [Abstract][Full Text] [Related]
12. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
[TBL] [Abstract][Full Text] [Related]
13. [Functional dyspepsia: definition, classification, clinical and therapeutic management].
Montalto M; Santoro L; Vastola M; Curigliano V; Cammarota G; Manna R; Gasbarrini G
Ann Ital Med Int; 2004; 19(2):84-9. PubMed ID: 15317268
[TBL] [Abstract][Full Text] [Related]
14. Differences in the diagnostic yield of upper gastrointestinal endoscopy in dyspeptic patients receiving proton-pump inhibitors and H2-receptor antagonists.
Mitchell RM; Collins JS; Watson RG; Tham TC
Endoscopy; 2002 Jul; 34(7):524-6. PubMed ID: 12170401
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
[TBL] [Abstract][Full Text] [Related]
16. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
17. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
Raghunath AS; Hungin AP; Mason J; Jackson W
Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
[TBL] [Abstract][Full Text] [Related]
18. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
Delaney B; McColl K
Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
[TBL] [Abstract][Full Text] [Related]
19. Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
Madsen LG; Wallin L; Bytzer P
Aliment Pharmacol Ther; 2004 Aug; 20(4):423-30. PubMed ID: 15298636
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia.
Gerson LB; Triadafilopoulos G
Dig Liver Dis; 2005 Feb; 37(2):87-91. PubMed ID: 15733519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
